Add to ORKGDocetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II stud
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
re i2, K Gastric cancer is the second leading cause of cancer death worldwide with approximately 989...
The aim was to investigate the activity of docetaxel in advanced gastric cancer either as single age...
Cisplatin is frequently used in Japan for the treatment of advanced gastric cancer [1–3]. Docetaxel ...
Background:Docetaxel plus cisplatin (DP) is a combination chemotherapy regimen that is active agains...
This randomized phase II trial evaluated two docetaxel-based regimens to see which would be most pro...
multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared...
Docetaxel-based chemotherapy appears to have considerable promise in advanced gastric cancer. In pha...
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
This randomized phase II trial evaluated two docetaxel-based regimens to see which would be most pro...
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric canc...
The combination of docetaxel with cisplatin in gastric cancer is a promising development. In a phase...
The combination of docetaxel with cisplatin in gastric cancer is a promising development. In a phase...
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusio...
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
re i2, K Gastric cancer is the second leading cause of cancer death worldwide with approximately 989...
The aim was to investigate the activity of docetaxel in advanced gastric cancer either as single age...
Cisplatin is frequently used in Japan for the treatment of advanced gastric cancer [1–3]. Docetaxel ...
Background:Docetaxel plus cisplatin (DP) is a combination chemotherapy regimen that is active agains...
This randomized phase II trial evaluated two docetaxel-based regimens to see which would be most pro...
multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared...
Docetaxel-based chemotherapy appears to have considerable promise in advanced gastric cancer. In pha...
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
This randomized phase II trial evaluated two docetaxel-based regimens to see which would be most pro...
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric canc...
The combination of docetaxel with cisplatin in gastric cancer is a promising development. In a phase...
The combination of docetaxel with cisplatin in gastric cancer is a promising development. In a phase...
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusio...
Background: Benefits of chemotherapy have generally been modest in gastric cancer, although those re...
re i2, K Gastric cancer is the second leading cause of cancer death worldwide with approximately 989...
The aim was to investigate the activity of docetaxel in advanced gastric cancer either as single age...